Showing results (11-20 of 45) with videos related to
Sort By:
Pageof 5
Cell and Tissue Research|April 1, 1989
Ultrastructural changes in the thymus of the turtle Mauremys caspica in relation to the seasonal cycleJ Leceta, E Garrido, M Torroba, et al.Cell and Tissue Research|January 1, 1981
Plasma cells in the ammocoete of Petromyzon marinusA Zapata, C F Ardavin, R P Gomariz, et al.Nature Medicine|May 1, 2001
Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the diseaseM Delgado, C Abad, C Martinez, et al.Peptides|January 1, 1996
Differential VIP and VIP1 receptor gene expression in rat thymocyte subsetsM Delgado, C Martínez, J Leceta, et al.Blood|June 15, 1996
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosisM Delgado, E Garrido, C Martinez, et al.Current Pharmaceutical Design|February 15, 2001
Immunology of VIP: a review and therapeutical perspectivesR P Gomariz, C Martinez, C Abad, et al.European Journal of Immunology|November 28, 2000
Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shockM Delgado, R P Gomariz, C Martinez, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2001
Pituitary adenylate cyclase-activating polypeptide inhibits collagen-induced arthritis: an experimental immunomodulatory therapyC Abad, C Martinez, J Leceta, et al.Annals of the New York Academy of Sciences|February 24, 2001
VIP and PACAP induce shift to a Th2 response by upregulating B7.2 expressionM Delgado, J Leceta, W Sun, et al.Advances in Neuroimmunology|January 1, 1996
Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune systemJ Leceta, C Martínez, M Delgado, et al.Pageof 5